Massive gaps in radiotherapy follow up care

gaps in radiotherapy follow up care

Patients suffering with debilitating symptoms due to gaps in radiotherapy follow up care: A new report has found cervical cancer patients treated with radiotherapy are not getting care to deal with long term side effects such as pain, incontinence and urgent bowel movements. A lack of recognition among healthcare professionals, and scarce resources to diagnose and […]

Read More… from Massive gaps in radiotherapy follow up care

Benefits of individualising radiotherapy

individualising radiotherapy

Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery San Antonio Breast Cancer Symposium (virtual SABCS 2020, 8-12 December, Texas, USA) Ductal carcinoma in situ (DCIS) of the breast is characterised by abnormal cells in the milk ducts which have not spread into the breast tissue. An international study (BIG 3-07/TROG 07.01) […]

Read More… from Benefits of individualising radiotherapy

COVID-19: cancer diagnosis and care

Cancer care and diagnosis

COVID-19: cancer diagnosis and care: Covid-19 may have changed the way people have been diagnosed with cancer and how they receive care – new study to investigate by Natasha Meredith of the University of Surrey An important new study from the University of Surrey and UCL is set to investigate how rapid changes in cancer […]

Read More… from COVID-19: cancer diagnosis and care

Cervical screening uptake 2019-20

cervical screening

Robert Music, Chief Executive, Jo’s Cervical Cancer Trust responds to the release of the annual cervical screening uptake statistics for England by NHS Digital. These figures cover the period from April 2019 – March 2020: In a ’normal’ year an increase in attendance could be a glimmer of hope. However, this year it must come with […]

Read More… from Cervical screening uptake 2019-20

IMPACT appoints Professor Ronjon Chakraverty as Medical Director

stem cell

IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer and stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director. Ronjon Chakraverty is currently Professor of Haematology at the University of Oxford. He previously led the merger of the Royal Free and University College London Hospital Haematology […]

Read More… from IMPACT appoints Professor Ronjon Chakraverty as Medical Director

Face to face appointments preferred over virtual

virtual

Lung cancer patients are more likely to worry about receiving bad news if offered a virtual (video or telephone) appointment, says a new report published today1 (26th November 2020) – supported by the Roy Castle Lung Cancer Foundation, British Thoracic Oncology Group, Lung Cancer Nursing UK and UK Lung Cancer Coalition. The report, which examines patients and health professionals’ perspectives on […]

Read More… from Face to face appointments preferred over virtual

Medical Reconstructive Tattoo Artistry by Alice Nicholls

Medical Reconstructive Tattoo Artistry: award winning tattoo artist Alice Nicholls has created a safe environment within her studio, where clients life stories and personal journeys are valued and listened to, creating a deeper understanding for their individual needs. The trauma of having undergone surgery, or a procedure leaving a person with life changing differences to […]

Read More… from Medical Reconstructive Tattoo Artistry by Alice Nicholls

80% say Britain has a drink problem

drink problem

Public calls for cancer warnings on alcohol as nearly 80% say Britain ‘has a drink problem’: Priory experts say lockdown has ‘loosened controls’ on people’s alcohol consumption, with job loss, and loneliness the most significant factors. A new poll shows mounting public concern about drinking levels in the UK, especially under lockdown, with almost 8 in […]

Read More… from 80% say Britain has a drink problem

Skin cancer treatment to help transplant patients

skin cancer treatment

World-first skin cancer treatment aims to help transplant patients: A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin cancers. The world-first treatment being developed at The University of Queensland is the only drug of its type that could prevent the incidence of skin cancers […]

Read More… from Skin cancer treatment to help transplant patients

Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth

CRYM

Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth: Prostate cancer is one of the most commonly diagnosed forms of cancer in men and affects around 5,600 men in Austria each year. Hormone therapy is one of the core treatment strategies, but it is only effective for a certain period of time. It has been known […]

Read More… from Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth